At a medical appointment, a patient shows their phone screen where an AI tool flags their symptoms as high-risk and recommends the next step. The language of the recommendation is polished and specific. The FDA has announced that it is easing regulation of digital health products, including AI and wearables. The change follows the Trump administration's promises to deregulate artificial intelligence. Commissioner Marty Makary informed about it in a speech at the Consumer Electronics Show. In Utah, they launched a pilot program in which AI renews routine drug prescriptions for patients with chronic diseases without the involvement of a doctor. The program is implemented by startup Doctronic and started last month. In California, AI is threatened with new regulations because of the mental health risks to children and adults.